| Old Articles: <Older 8751-8760 Newer> |
 |
The Motley Fool July 28, 2005 Stephen D. Simpson |
Should PetroKazakhstan Be Pumped? Despite involuntary production cuts, this Canadian oil company still managed to beat expectations and post a solid result.  |
The Motley Fool July 28, 2005 Rich Smith |
Strike Three for Hooker The furniture manufacturer announced that that it will close its third plant in as many years. Investors are less than eager to stick around to see how its latest plan plays out.  |
The Motley Fool July 28, 2005 Stephen D. Simpson |
Bristol-Myers' Road to Better Health Bristol-Myers looks toward 2007 and a resumption of real growth. For now, things could be a lot worse. At least investors can't say they're not getting paid to be patient.  |
The Motley Fool July 28, 2005 Shannon Zimmerman |
ConocoPhillips Pumps Up Earnings Rising oil prices boost ConocoPhillips' earnings, but how long will the party last? Investors intent on drilling for further profits in the energy sector should probably eye the industry's bigger players.  |
The Motley Fool July 28, 2005 Stephen D. Simpson |
Is LSI Lying in Wait? LSI Logic will need to change from within if it wants to be anything more than a plaything of the semiconductor cycle. Investors, take note.  |
The Motley Fool July 28, 2005 Rich Duprey |
Chiron's Tragic Quarter The biotech vaccine maker barely breaks even but boasts of its ability to meet full-year expectations.  |
The Motley Fool July 28, 2005 Nathan Parmelee |
Rubbermaid Seals and Delivers Newell Rubbermaid's restructuring begins to bear fruit. With the debt load continuing to shrink, it looks as though the company could easily fund increases of the 3.2% dividend yield.  |
The Motley Fool July 28, 2005 Mike Cianciolo |
Stanley Works Acquires Its Way to Growth The nation's leading toolmaker continues to build solid growth. The company projects full-year earnings of $3.20 to $3.30 per diluted share, which would represent an increase of 12% to 16% over last year's earnings.  |
The Motley Fool July 28, 2005 Chuck Saletta |
Let Cash Be Your Guide Use the cash flow statement to weed out financial shenanigans and uncover hidden stock values.  |
The Motley Fool July 28, 2005 Stephen D. Simpson |
Glaxo Keeps It Going Despite missing sales from the depression franchise, Glaxo managed to post respectable quarterly results.  |
| <Older 8751-8760 Newer> Return to current articles. |